Medical trainee and Allied Health Representatives on the Cystic Fibrosis National Research Strategy Group (CF NRSG) | Call for applications
NIHR has opened applications for Medical trainee (adult or paediatric) and Allied Health Representatives on the Cystic Fibrosis National Research Strategy Group. Please see below, information regarding the application from NIHR.
Background
- NIHR Respiratory TRC
The Respiratory Translation Research Collaboration (Respiratory-TRC) brings together leading internationally recognised investigators in the UK’s foremost centres of excellence to collaborate on delivering experimental and early phase research with industry, charities and other funders. Together we can design and deliver complex multi-centre studies that accelerate research for the benefit of respiratory disease patients.
- Respiratory-TRC hosts the National Research Strategy Groups (NRSGs). These are disease specific workgroups with the potential for to collaborate with industry and others across respiratory disease priority areas in translational research and early phase experimental medicine. Respiratory TRC has set-up 6 nationwide National Research Strategy Groups (NRSGs) to identify key research priorities and develop strategies to overcome barriers and promote collaborative working to deliver multi-centre studies. Their membership is wide reaching across multiple sites, well beyond the 13 key R-TRC centres.
- CF NRSG
The CF-NRSG is led by Prof Jane Davies (Imperial) and Prof Damian Downey (Belfast) with membership from UK and overseas comprising clinical academics and research active clinicians, including BRCs with a respiratory theme as well as representation from all 4 UK nations; the research and PPIE leads of the UK CF Trust; the lead of the UK CF Patient Registry; and an external expert (Egan, Yale, Genetic Therapies).
- Links
Through our membership, we have links with every aspect of CF research infrastructure, including the UK Clinical Trials Accelerator Platform and European CF Society Clinical Trials Network, Medicines Discovery Catapult/ CFT/ LifeArc Syndicate for Antimicrobial Resistance, CF Foundation (US) Genetic Therapies Working Group and James Lind Priority Setting Partnership. We are working with these to expand our existing portfolio of activities, attract new industrial partners, and develop new research activities based on recently refreshed patient priorities.
- Aims
By building on the established infrastructure in CF, the group aims to maximise the effective delivery and outputs of research and to drive new collaborations based on patient priorities.
- Role and responsibilities
Attend 3-4 meetings/ year; these will usually be on line and last 1-2 hours Respond to requests for information and cascade as advised Input into activities of the NRSG: drafting and reviewing manuscripts; conferences/ meetings
- Personal specification
Evidence of ongoing, active involvement in CF research Enthusiasm for collaboration, networking and driving change
Please send a short personal statement (< 1 page A4) describing why you wish to join the group and would make a useful contribution, plus your current CV via email to:
Maria Marsh
Translational Research Collaboration Manager
NIHR Respiratory Translational Research Collaboration
Deadline for applications to be received: 5 pm, Friday 9th May
Find out more about the Respiratory TRC Visit this website: R-TRC
